|
Dr. Frost co-founded Halozyme in 1999 and has spent more than twelve years researching the hyaluronidase family of enzymes. From 1998 to 1999 he was a Senior Research Scientist at the Sidney Kimmel Cancer Center (SKCC) where he focused much of his work developing the hyaluronidase technology. Prior to SKCC his research in the Department of Pathology at the University of California San Francisco led directly to the purification cloning and characterization of the human hyaluronidase gene family and the discovery of several metabolic disorders. He has authored multiple scientific peer-reviewed and invited articles in the Hyaluronidase field and is an inventor on several key patents. Dr. Frost’s prior experience includes serving as a scientific consultant to a number of biopharmaceutical companies including Q-Med (SE) Biophausia AB (SE) and Active Biotech (SE). Dr. Frost is registered to practice before the US Patent Trademark Office and earned his BA in biochemistry and molecular biology from the University of California Santa Cruz and his Ph.D. in the department of Pathology at the University of California San Francisco where he was an ARCS-Scholar. | 